BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10836212)

  • 21. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
    Cheema Y; Olson S; Elson D; Chen H
    J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Total thyroidectomy of choice in papillary microcarcinoma].
    Pisello F; Geraci G; Sciumè C; Li Volsi F; Modica G
    G Chir; 2007; 28(1-2):13-9. PubMed ID: 17313727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma.
    Michels JJ; Jacques M; Henry-Amar M; Bardet S
    Hum Pathol; 2007 Feb; 38(2):212-9. PubMed ID: 17097131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature].
    Satge D; Grob JC; Pusel J; Methlin G
    Arch Anat Cytol Pathol; 1990; 38(4):143-51. PubMed ID: 2221999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
    Sugitani I; Fujimoto Y; Yamamoto N
    Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up.
    Neuhold N; Schultheis A; Hermann M; Krotla G; Koperek O; Birner P
    Ann Surg Oncol; 2011 Nov; 18(12):3430-6. PubMed ID: 21431405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of differentiated microcarcinomas of the thyroid.
    Ruggieri M; Genderini M; Gargiulo P; Del Grammastro A; Mascaro A; Luongo B; Paolini A
    Eur Rev Med Pharmacol Sci; 2001; 5(3):85-9. PubMed ID: 12004917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thyroid microcarcinoma in benign thyroid diseases].
    Costanzo M; Caruso LA; Messina DC; Cavallaro A; Palumbo A; Marziani A; Cannizzaro MA
    Ann Ital Chir; 2005; 76(2):119-21; discussion 121-2. PubMed ID: 16302649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
    Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
    Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microcarcinoma and incidental carcinoma of the thyroid in a clinical series: clinical behaviour and surgical management.
    Antonaci A; Anello A; Aucello A; Consorti F; Della Rocca C; Giovannone G; Scardella L
    Clin Ter; 2006; 157(3):225-9. PubMed ID: 16900848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of papillary microcarcinoma of the thyroid.
    Haas SN
    S D Med; 2006 Oct; 59(10):425-7. PubMed ID: 17124919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcarcinoma of the thyroid.
    Baloch ZW; LiVolsi VA
    Adv Anat Pathol; 2006 Mar; 13(2):69-75. PubMed ID: 16670460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?
    Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P
    Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancer.
    Wiseman SM; Loree TR; Rigual NR; Hicks WL; Winston JS; Swede H; Bartos JD; Anderson GR; Stoler DL
    Head Neck; 2003 Oct; 25(10):825-32. PubMed ID: 12966506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A special case of bilateral ovarian metastases in a woman with papillary carcinoma of the thyroid.
    Brogioni S; Viacava P; Tomisti L; Martino E; Macchia E
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):397-400. PubMed ID: 17701887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.